checkAd

     101  0 Kommentare Ascent Industries Reports Second Quarter 2023 Results

    Ascent Industries Co. (Nasdaq: ACNT) (“Ascent” or the “Company”), an industrials company focused on the production and distribution of industrial tubular products and specialty chemicals, is reporting its results for the second quarter ended June 30, 2023.

    Second Quarter 2023 Summary – Continuing Operations1

    (in millions, expect per share and margin)

    Q2 2023

    Q2 2022

    Change

    Net Sales

    $60.7

    $84.6

    -28.3%

    Gross Profit

    $3.2

    $20.2

    -84.0%

    Gross Profit Margin

    5.3%

    23.9%

    -1860bps

    Net Income (Loss)

    $(3.7)

    $10.8

    -134.8%

    Diluted Earnings (Loss) per Share

    $(0.37)

    $1.04

    -135.6%

    Adjusted EBITDA

    $(1.5)

    $14.8

    -110.0%

    Adjusted EBITDA Margin

    (2.4)%

    17.4%

    -1980bps

    1On June 2, 2023, the Board of Directors of Ascent made the decision to permanently cease operations at the Company’s welded pipe and tube facility located in Munhall, PA (“Munhall”) effective on or around August 31, 2023. As a result, financial results from Munhall have been categorized into discontinued operations.

    Management Commentary

    “Challenges related to the strategic changes we’ve implemented over the last several quarters, along with difficult end market conditions impacting demand, continued to persist in the second quarter,” said Chris Hutter, president and CEO of Ascent. “Despite this difficult environment, our organization took action by finalizing the permanent closure of our Munhall operations, as well as managing working capital effectively to generate cash and pay down debt. We believe our tubular products segment is on a path to improve through the remainder of the year, while we continue to work on expanding our sales pipeline within the specialty chemicals segment to drive long-term, profitable growth.

    “We remain highly committed to executing our strategic goals and believe the operational changes we’ve made will significantly benefit the Company’s value proposition over the long-term. Although the work is never done, we have made tangible progress to right-size our operational footprint, create a more efficient organization, and implement a refreshed culture based on accountability and performance-based results. We believe the largest hurdles are now behind us and expect to begin seeing improvements through the remainder of the year.”

    Second Quarter 2023 Financial Results

    Net sales from continuing operations were $60.7 million compared to $84.6 million in the prior year period. The decrease is primarily due to lower overall sales volumes and lower average selling prices within both the tubular products and specialty chemicals segments.

    Gross profit from continuing operations was $3.2 million, or 5.3% of net sales, compared to $20.2 million, or 23.9% of net sales, in the second quarter of 2022. The decrease is primarily attributable to the decline in net sales in addition to increased raw material and labor costs.

    Net loss from continuing operations was $3.7 million, or $(0.37) diluted loss per share, compared to net income from continuing operations of $10.8 million, or $1.04 diluted earnings per share, in the second quarter of 2022. The decrease is primarily attributable to the aforementioned decline in gross profit and higher interest expense.

    Adjusted EBITDA was $(1.5) million compared to $14.8 million in the second quarter of 2022. Adjusted EBITDA margin was (2.4)% compared to 17.4% in the prior year period. The decrease is primarily attributable to the Company’s aforementioned decline in net sales.

    Segment Results

    Ascent Tubular net sales from continuing operations in the second quarter of 2023 were $39.3 million compared to $55.6 million in the second quarter of 2022. Operating loss from continuing operations in the second quarter was $0.1 million compared to operating income from continuing operations of $13.0 million in the prior year period. Adjusted EBITDA from continuing operations in the second quarter was $0.8 million compared to $14.2 million in the prior year period. As a percentage of segment net sales, adjusted EBITDA was 2.1% compared to 25.6% in the second quarter of 2022.

    Ascent Chemicals net sales in the second quarter of 2023 were $21.4 million compared to $29.0 million in the second quarter of 2022. Operating loss in the second quarter was $0.8 million compared to operating income of $2.6 million in the prior year period. Adjusted EBITDA in the second quarter was $0.3 million compared to $3.6 million in the prior year period. As a percentage of segment net sales, adjusted EBITDA was 1.5% compared to 12.6% in the second quarter of 2022.

    Liquidity

    As of June 30, 2023, total debt was $54.5 million under the Company’s revolving credit facility, compared to $71.5 million in debt at December 31, 2022. As of June 30, 2023, the Company had $45.4 million of remaining available borrowing capacity under its revolving credit facility, compared to $37.6 million at December 31, 2022.

    During the second quarter of 2023, the Company repurchased 18,843 shares at an average cost of $9.34 per share for approximately $0.2 million, bringing total year-to-date repurchases for 2023 to 51,156 shares. The Company currently has 628,823 shares remaining under its share repurchase authorization.

    Conference Call

    Ascent will conduct a conference call today at 5:00 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2023.

    Ascent management will host the conference call, followed by a question and answer period.

    Date: Tuesday, August 8, 2023
    Time: 5:00 p.m. Eastern time
    Live Call Registration Link: Here
    Webcast Registration Link: Here

    Please call the conference telephone number five minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group at 1-949-574-3860.

    The conference call will also be broadcast live and available for replay here. The webcast will be archived for one year in the investor relations section of the Company’s website at www.ascentco.com.

    About Ascent Industries Co.

    Ascent Industries Co. (Nasdaq: ACNT) is a company that engages in a number of diverse business activities including the production of stainless steel, the master distribution of seamless carbon pipe and tube, and the production of specialty chemicals. For more information about Ascent, please visit its web site at www.ascentco.com.

    Forward-Looking Statements

    This press release may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable federal securities laws. All statements that are not historical facts are forward-looking statements. Forward looking statements can be identified through the use of words such as "estimate," "project," "intend," "expect," "believe," "should," "anticipate," "hope," "optimistic," "plan," "outlook," "should," "could," "may" and similar expressions. The forward-looking statements are subject to certain risks and uncertainties which could cause actual results to differ materially from historical results or those anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements and to review the risks as set forth in more detail in Ascent Industries Co.’s Securities and Exchange Commission filings, including our Annual Report on Form 10-K, which filings are available from the SEC or on our website. Ascent Industries Co. assumes no obligation to update any forward-looking information included in this release.

    Non-GAAP Financial Information

    Financial statement information included in this earnings release includes non-GAAP (Generally Accepted Accounting Principles) measures and should be read along with the accompanying tables which provide a reconciliation of non-GAAP measures to GAAP measures.

    Adjusted EBITDA is a non-GAAP financial measure that the Company believes is useful to investors in evaluating its results to determine the value of a company. An item is excluded in the measure if its periodic value is inconsistent and sufficiently material that not identifying the item would render period comparability less meaningful to the reader or if including the item provides a clearer representation of normalized periodic earnings. The Company excludes in Adjusted EBITDA two categories of items: 1) Base EBITDA components, including: interest expense (including change in fair value of interest rate swap), income taxes, depreciation and amortization, and 2) Material transaction costs including: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, proxy contest costs and recoveries, shelf registration costs, loss on extinguishment of debt, earn-out adjustments, realized and unrealized (gains) and losses on investments in equity securities and other investments, retention costs and restructuring & severance costs from net income.

    Management believes that these non-GAAP measures are useful because they are key measures used by our management team to evaluate our operating performance, generate future operating plans and make strategic decisions as well as allow readers to compare the financial results between periods. Non-GAAP measures should not be considered as an alternative to any measure of performance or financial condition as promulgated under GAAP, and investors should consider the Company's performance and financial condition as reported under GAAP and all other relevant information when assessing the performance or financial condition of the Company. Non-GAAP measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the Company's results or financial condition as reported under GAAP.

    Ascent Industries Co.

    Condensed Consolidated Balance Sheets

    (in thousands, except par value and share data)

     

    (Unaudited)

     

     

     

    June 30, 2023

     

    December 31, 2022

    Assets

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    717

     

     

    $

    1,440

     

    Accounts receivable, net of allowance for credit losses of $734 and $762, respectively

     

    35,053

     

     

     

    37,062

     

    Inventories

     

    74,300

     

     

     

    85,572

     

    Prepaid expenses and other current assets

     

    9,186

     

     

     

    7,802

     

    Assets held for sale

     

    17,398

     

     

     

    380

     

    Current assets of discontinued operations

     

    3,441

     

     

     

    38,120

     

    Total current assets

     

    140,095

     

     

     

    170,376

     

    Property, plant and equipment, net

     

    34,364

     

     

     

    37,045

     

    Right-of-use assets, operating leases, net

     

    28,509

     

     

     

    29,198

     

    Goodwill

     

    11,389

     

     

     

    11,389

     

    Intangible assets, net

     

    9,248

     

     

     

    10,001

     

    Deferred income taxes

     

    6,869

     

     

     

    1,353

     

    Deferred charges, net

     

    153

     

     

     

    203

     

    Other non-current assets, net

     

    1,782

     

     

     

    1,861

     

    Long-term assets of discontinued operations

     

    13

     

     

     

    7,617

     

    Total assets

    $

    232,422

     

     

    $

    269,043

     

     

     

     

     

    Liabilities and Shareholders' Equity

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    22,242

     

     

    $

    19,623

     

    Accrued expenses and other current liabilities

     

    5,504

     

     

     

    6,039

     

    Current portion of note payable

     

    900

     

     

     

    387

     

    Current portion of long-term debt

     

    2,464

     

     

     

    2,464

     

    Current portion of operating lease liabilities

     

    1,093

     

     

     

    1,029

     

    Current portion of finance lease liabilities

     

    283

     

     

     

    280

     

    Current liabilities of discontinued operations

     

    1,839

     

     

     

    3,656

     

    Total current liabilities

     

    34,325

     

     

     

    33,478

     

    Long-term debt

     

    52,056

     

     

     

    69,085

     

    Long-term portion of operating lease liabilities

     

    30,338

     

     

     

    30,911

     

    Long-term portion of finance lease liabilities

     

    1,313

     

     

     

    1,242

     

    Other long-term liabilities

     

    64

     

     

     

    68

     

    Total non-current liabilities

     

    83,771

     

     

     

    101,306

     

    Total liabilities

    $

    118,096

     

     

    $

    134,784

     

     

     

     

     

    Commitments and contingencies

     

     

     

     

     

     

     

    Shareholders' equity:

     

     

     

    Common stock, par value $1 per share; 24,000,000 shares authorized; 11,085,103 and 10,158,219 shares issued and outstanding, respectively

    $

    11,085

     

     

    $

    11,085

     

    Capital in excess of par value

     

    46,951

     

     

     

    47,021

     

    Retained earnings

     

    65,311

     

     

     

    85,146

     

     

     

    123,347

     

     

     

    143,252

     

    Less: cost of common stock in treasury - 926,884 and 924,504 shares, respectively

     

    (9,021

    )

     

     

    (8,993

    )

    Total shareholders' equity

     

    114,326

     

     

     

    134,259

     

    Total liabilities and shareholders' equity

    $

    232,422

     

     

    $

    269,043

     

    Note: The condensed consolidated balance sheets at December 31, 2022 have been derived from the audited consolidated financial statements at that date.

     

    Ascent Industries Co.

    Condensed Consolidated Statements of Income (Loss) - Comparative Analysis (Unaudited)

    ($ in thousands, except per share data)

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2023

     

     

     

    2022

     

     

     

    2023

     

     

     

    2022

     

    Net sales

     

     

     

     

     

     

     

     

    Tubular Products

    $

    39,302

     

     

    $

    55,580

     

     

    $

    82,922

     

     

    $

    111,454

     

     

    Specialty Chemicals

     

    21,363

     

     

     

    29,020

     

     

     

    45,112

     

     

     

    56,741

     

     

    All Other

     

     

     

     

     

     

     

    50

     

     

     

    114

     

     

     

     

    60,665

     

     

     

    84,600

     

     

     

    128,084

     

     

     

    168,309

     

    Operating income (loss) from continuing operations

     

     

     

     

     

     

     

    Tubular Products

     

    (105

    )

     

     

    12,992

     

     

     

    1,560

     

     

     

    27,120

     

     

    Specialty Chemicals

     

    (806

    )

     

     

    2,627

     

     

     

    546

     

     

     

    5,014

     

     

    All Other

     

    (74

    )

     

     

    (235

    )

     

     

    (552

    )

     

     

    (317

    )

     

     

     

     

     

     

     

     

     

    Corporate

     

     

     

     

     

     

     

     

    Unallocated corporate expenses

     

    (2,750

    )

     

     

    (3,322

    )

     

     

    (6,455

    )

     

     

    (6,351

    )

     

    Acquisition costs and other

     

    (17

    )

     

     

    (157

    )

     

     

    (274

    )

     

     

    (688

    )

     

    Total Corporate

     

    (2,767

    )

     

     

    (3,479

    )

     

     

    (6,729

    )

     

     

    (7,039

    )

     

    Operating income (loss)

     

    (3,752

    )

     

     

    11,905

     

     

     

    (5,175

    )

     

     

    24,778

     

     

    Interest expense

     

    1,047

     

     

     

    407

     

     

     

    2,154

     

     

     

    810

     

     

    Other, net

     

    (154

    )

     

     

    (23

    )

     

     

    (247

    )

     

     

    (58

    )

    Income (loss) from continuing operations before income taxes

     

    (4,645

    )

     

     

    11,521

     

     

     

    (7,082

    )

     

     

    24,026

     

     

    Income tax provision (benefit)

     

    (897

    )

     

     

    699

     

     

     

    (1,385

    )

     

     

    3,197

     

     

    Income (loss) from continuing operations

     

    (3,748

    )

     

     

    10,822

     

     

     

    (5,697

    )

     

     

    20,829

     

     

    Income (loss) from discontinued operations, net of tax

     

    (10,888

    )

     

     

    235

     

     

     

    (14,138

    )

     

     

    488

     

    Net income (loss)

    $

    (14,636

    )

     

    $

    11,057

     

     

    $

    (19,835

    )

     

    $

    21,317

     

     

     

     

     

     

     

     

     

     

    Net income (loss) per common share from continuing operations

     

     

     

     

     

     

     

     

    Basic

    $

    (0.37

    )

     

    $

    1.06

     

     

    $

    (0.56

    )

     

    $

    2.04

     

     

    Diluted

    $

    (0.37

    )

     

    $

    1.04

     

     

    $

    (0.56

    )

     

    $

    2.01

     

     

     

     

     

     

     

     

     

     

    Net income (loss) per common share from discontinued operations

     

     

     

     

     

     

     

     

    Basic

    $

    (1.07

    )

     

    $

    0.02

     

     

    $

    (1.39

    )

     

    $

    0.05

     

     

    Diluted

    $

    (1.07

    )

     

    $

    0.02

     

     

    $

    (1.39

    )

     

    $

    0.05

     

     

     

     

     

     

     

     

     

     

    Net income (loss) per common share

     

     

     

     

     

     

     

     

    Basic

    $

    (1.44

    )

     

    $

    1.08

     

     

    $

    (1.95

    )

     

    $

    2.08

     

     

    Diluted

    $

    (1.44

    )

     

    $

    1.06

     

     

    $

    (1.95

    )

     

    $

    2.05

     

     

     

     

     

     

     

     

     

     

    Average shares outstanding

     

     

     

     

     

     

     

     

    Basic

     

    10,170

     

     

     

    10,244

     

     

     

    10,159

     

     

     

    10,226

     

     

    Diluted

     

    10,170

     

     

     

    10,431

     

     

     

    10,159

     

     

     

    10,377

     

     

     

     

     

     

     

     

     

     

    Other data:

     

     

     

     

     

     

     

     

    Adjusted EBITDA1

    $

    (1,471

    )

     

    $

    14,751

     

     

    $

    (166

    )

     

    $

    30,680

     

    1The term Adjusted EBITDA is a non-GAAP financial measure that the Company believes is useful to investors in evaluating its results to determine the value of a company. An item is excluded in the measure if its periodic value is inconsistent and sufficiently material that not identifying the item would render period comparability less meaningful to the reader or if including the item provides a clearer representation of normalized periodic earnings. The Company excludes in Adjusted EBITDA two categories of items: 1) Base EBITDA components, including: interest expense (including change in fair value of interest rate swap), income taxes, depreciation and amortization, and 2) Material transaction costs including: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, proxy contest costs and recoveries, loss on extinguishment of debt, earn-out adjustments, realized and unrealized (gains) and losses on investments in equity securities and other investments, retention costs and restructuring & severance costs from net income. For a reconciliation of this non-GAAP measure to the most comparable GAAP equivalent, refer to the Reconciliation of Net Income (Loss) to Adjusted EBITDA.

     

    Ascent Industries Co.

    Consolidated Statements of Cash Flows (Unaudited)

    ($ in thousands)

     

    Six Months Ended June 30,

     

    2023

     

    2022

    Operating activities

     

     

     

    Net income (loss)

    $

    (19,835

    )

     

    $

    21,317

     

    Net income (loss) from discontinued operations, net of tax

     

    (14,138

    )

     

     

    488

     

    Net income (loss) from continuing operations

     

    (5,697

    )

     

     

    20,829

     

    Adjustments to reconcile net income (loss) to net cash provided by operating activities:

     

     

     

    Depreciation expense

     

    3,243

     

     

     

    3,201

     

    Amortization expense

     

    753

     

     

     

    1,343

     

    Amortization of debt issuance costs

     

    50

     

     

     

    49

     

    Deferred income taxes

     

    (5,515

    )

     

     

    (642

    )

    Payments of earn-out liabilities in excess of acquisition date fair value

     

     

     

     

    (372

    )

    (Reduction of) provision for losses on accounts receivable

     

    (28

    )

     

     

    459

     

    Provision for losses on inventories

     

    1,190

     

     

     

    863

     

    Loss (gain) on disposal of property, plant and equipment

     

    182

     

     

     

    (5

    )

    Non-cash lease expense

     

    137

     

     

     

    214

     

    Issuance of treasury stock for director fees

     

     

     

     

    364

     

    Stock-based compensation expense

     

    414

     

     

     

    446

     

    Changes in operating assets and liabilities:

     

     

     

    Accounts receivable

     

    2,037

     

     

     

    (10,173

    )

    Inventories

     

    10,279

     

     

     

    (27,738

    )

    Other assets and liabilities

     

    (295

    )

     

     

    (755

    )

    Accounts payable

     

    2,095

     

     

     

    14,476

     

    Accrued expenses

     

    (587

    )

     

     

    (1,980

    )

    Accrued income taxes

     

    (743

    )

     

     

    110

     

    Net cash provided by operating activities - continuing operations

     

    7,515

     

     

     

    689

     

    Net cash provided by operating activities - discontinued operations

     

    10,557

     

     

     

    2,200

     

    Net cash provided by operating activities

     

    18,072

     

     

     

    2,889

     

    Investing activities

     

     

     

    Purchases of property, plant and equipment

     

    (1,483

    )

     

     

    (1,981

    )

    Proceeds from disposal of property, plant and equipment

     

     

     

     

    5

     

    Net cash used in investing activities - continuing operations

     

    (1,483

    )

     

     

    (1,976

    )

    Net cash used in investing activities - discontinued operations

     

    (142

    )

     

     

    (349

    )

    Net cash used in investing activities

     

    (1,625

    )

     

     

    (2,325

    )

    Financing activities

     

     

     

    Borrowings from long-term debt

     

    139,137

     

     

     

    237,938

     

    Proceeds from note payable

     

    900

     

     

     

    967

     

    Proceeds from the exercise of stock options

     

     

     

     

    161

     

    Payments on long-term debt

     

    (156,166

    )

     

     

    (240,017

    )

    Payments on note payable

     

    (387

    )

     

     

    (96

    )

    Principal payments on finance lease obligations

     

    (151

    )

     

     

    (126

    )

    Payments on earn-out liabilities

     

     

     

     

    (484

    )

    Repurchase of common stock

     

    (504

    )

     

     

     

    Net cash used in financing activities - continuing operations

     

    (17,171

    )

     

     

    (1,657

    )

    Net cash used in financing activities - discontinued operations

     

     

     

     

    (683

    )

    Net cash used in financing activities

     

    (17,171

    )

     

     

    (2,340

    )

    Decrease in cash and cash equivalents

     

    (724

    )

     

     

    (1,776

    )

    Less: Cash and cash equivalents of discontinued operations

     

    1

     

     

     

    4

     

    Cash and cash equivalents, beginning of period

     

    1,440

     

     

     

    2,017

     

    Cash and cash equivalents, end of period

    $

    717

     

     

    $

    245

     

    Ascent Industries Co.

    Non-GAAP Financial Measures Reconciliation

    Reconciliation of Net Income to Adjusted EBITDA (Unaudited)

    ($ in thousands)

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

    ($ in thousands)

    2023

     

    2022

     

    2023

     

    2022

    Consolidated

     

     

     

     

     

     

     

    Net income (loss) from continuing operations

    $

    (3,748

    )

     

    $

    10,822

     

     

    $

    (5,697

    )

     

    $

    20,687

     

    Adjustments:

     

     

     

     

     

     

     

     

    Interest expense

     

    1,047

     

     

     

    407

     

     

     

    2,154

     

     

     

    810

     

     

    Income taxes

     

    (897

    )

     

     

    699

     

     

     

    (1,385

    )

     

     

    3,339

     

     

    Depreciation

     

    1,632

     

     

     

    1,621

     

     

     

    3,243

     

     

     

    3,201

     

     

    Amortization

     

    376

     

     

     

    672

     

     

     

    753

     

     

     

    1,343

     

    EBITDA

     

    (1,590

    )

     

     

    14,221

     

     

     

    (932

    )

     

     

    29,380

     

     

    Acquisition costs and other

     

    20

     

     

     

    157

     

     

     

    280

     

     

     

    688

     

     

    Gain on lease modification

     

     

     

     

    (2

    )

     

     

     

     

     

    (2

    )

     

    Stock-based compensation

     

    24

     

     

     

    258

     

     

     

    246

     

     

     

    390

     

     

    Non-cash lease expense

     

    68

     

     

     

    107

     

     

     

    137

     

     

     

    214

     

     

    Restructuring and severance costs

     

    7

     

     

     

    10

     

     

     

    103

     

     

     

    10

     

    Adjusted EBITDA

    $

    (1,471

    )

     

    $

    14,751

     

     

    $

    (166

    )

     

    $

    30,680

     

     

    % sales

     

    (2.4

    )%

     

     

    17.4

    %

     

     

    (0.1

    )%

     

     

    18.2

    %

     

     

     

     

     

     

     

     

     

    Tubular Products

     

     

     

     

     

     

     

    Net income (loss) from continuing operations

    $

    (105

    )

     

    $

    12,993

     

     

    $

    1,560

     

     

    $

    27,120

     

    Adjustments:

     

     

     

     

     

     

     

     

    Depreciation expense

     

    653

     

     

     

    688

     

     

     

    1,290

     

     

     

    1,363

     

     

    Amortization expense

     

    218

     

     

     

    576

     

     

     

    436

     

     

     

    1,152

     

    EBITDA

     

    766

     

     

     

    14,257

     

     

     

    3,286

     

     

     

    29,635

     

     

    Acquisition costs and other

     

    4

     

     

     

     

     

     

    4

     

     

     

     

     

    Stock-based compensation

     

    10

     

     

     

    (16

    )

     

     

    (9

    )

     

     

    19

     

     

    Non-cash lease expense

     

    36

     

     

     

    (1

    )

     

     

    72

     

     

     

    (1

    )

     

    Restructuring and severance costs

     

     

     

     

     

     

     

    97

     

     

     

     

    Tubular Products Adjusted EBITDA

    $

    816

     

     

    $

    14,240

     

     

    $

    3,450

     

     

    $

    29,653

     

     

    % segment sales

     

    2.1

    %

     

     

    25.6

    %

     

     

    4.2

    %

     

     

    26.6

    %

     

     

     

     

     

     

     

     

     

    Specialty Chemicals

     

     

     

     

     

     

     

    Net income (loss)

    $

    (818

    )

     

    $

    2,617

     

     

    $

    523

     

     

    $

    4,995

     

    Adjustments:

     

     

     

     

     

     

     

     

    Interest expense

     

    18

     

     

     

    9

     

     

     

    31

     

     

     

    18

     

     

    Depreciation expense

     

    956

     

     

     

    915

     

     

     

    1,908

     

     

     

    1,800

     

     

    Amortization expense

     

    158

     

     

     

    96

     

     

     

    317

     

     

     

    192

     

    EBITDA

     

    314

     

     

     

    3,637

     

     

     

    2,779

     

     

     

    7,005

     

     

    Acquisition costs and other

     

     

     

     

     

     

     

    2

     

     

     

     

     

    Stock-based compensation

     

    (23

    )

     

     

    11

     

     

     

    (16

    )

     

     

    18

     

     

    Non-cash lease expense

     

    22

     

     

     

     

     

     

    46

     

     

     

     

    Specialty Chemicals Adjusted EBITDA

    $

    313

     

     

    $

    3,648

     

     

    $

    2,811

     

     

    $

    7,023

     

     

    % segment sales

     

    1.5

    %

     

     

    12.6

    %

     

     

    6.2

    %

     

     

    12.4

    %

     


    The Ascent Industries Stock at the time of publication of the news with a raise of +6,61 % to 8,875USD on Lang & Schwarz stock exchange (08. August 2023, 22:18 Uhr).


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Ascent Industries Reports Second Quarter 2023 Results Ascent Industries Co. (Nasdaq: ACNT) (“Ascent” or the “Company”), an industrials company focused on the production and distribution of industrial tubular products and specialty chemicals, is reporting its results for the second quarter ended June …